Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Name: Lexaria Bioscience Corp: Is Infosys Ltd. worth buying?
Item: Lexaria Bioscience Corp
Rating: 1.02408325
Author: Trendlyne DVM scores

about

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

0.63 0.03 (5.00%)

59.35% Fall from 52W High

82,114.6

XNAS Volume

XNAS 14 May, 2026 1:31 PM (EDT)

Not Eligible

Expensive Valuation

13.3 / 100

Technically Bearish

27.6 / 100

1Yr Price target upside is 495%

2 analysts

Lexaria Bioscience Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

59.35% Fall from 52W High

SWOT Analysis

Lexaria Bioscience Corp Live Price Chart